Azuma J, Sawamura A, Awata N. Usefulness of taurine in chronic congestive heart failure and its prospective application.
Jpn Circ J.
1992;56:95-99.
Matsuyama Y, Morita T, Higuchi M, et al. The effect of taurine administration on patients with acute hepatitis.
Prog Clin Biol Res.
1983;125:461-468.
Yamori Y, Horie R, Nara Y, Kihara M, Tada M. Studies on stroke prevention in animal models, and their supportable epidemiological evidence. As cited in H Barnett, et al, eds. Cerebrovascular diseases: new trends in surgical and medical aspects. Amsterdam: Elsevier/North Holland, 1981:47-62.
Franconi F, Bennardini F, Mattana A, et al. Plasma and platelet taurine are reduced in subjects with insulin-dependent diabetes mellitus: Effects of taurine supplementation.
Am J Clin Nutr. 1995;61:1115-1119.
Marchesi GF, Quattrini A, Scarpino O, et al. Therapeutic effects of taurine in epilepsy: a clinical and polyphysiographic study [in Italian; English abstract].
Riv Patol Nerv Ment. 1975;96:166-184.
Fukuyama Y, Ochiai Y. Therapeutic trial by taurine for intractable childhood epilepsies.
Brain Dev. 1982;4:63-69.
Podda M, Ghezzi C, Battezzati PM, et al. Effects of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis.
Gastroenterology. 1990;98:1044-1050.
Azuma J, Sawamura A, Awata N, et al. Double-blind randomized crossover trial of taurine in congestive heart failure.
Curr Ther Res. 1983;34:543-557.
Azuma J, Sawamura A, Awata N, et al. Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial.
Clin Cardiol. 1985;8:276-282.
Azuma J, Takihara K, Awata N, et al. Taurine and failing heart: Experimental and clinical aspects.
Prog Clin Biol Res. 1985;179:195-213.
Azuma J, Hasegawa H, Sawamura A, et al. Therapy of congestive heart failure with orally administered taurine.
Clin Ther. 1983;5:398-408.
Takihara K, Azuma J, Awata N, et al. Beneficial effect of taurine in rabbits with chronic congestive heart failure.
Am Heart J. 1986;112:1278-1284.
Azuma J, Takihara K, Awata N, et al. Beneficial effect of taurine on congestive heart failure induced by chronic aortic regurgitation in rabbits.
Res Commun Chem Pathol Pharmacol.
1984;45:261-270.
Azuma J, Sawamura A, Awata N. Usefulness of taurine in chronic congestive heart failure and its prospective application.
Jpn Circ J. 1992;56:95-99.
Matsuyama Y, Morita T, Higuchi M, et al. The effect of taurine administration on patients with acute hepatitis.
Prog Clin Biol Res.
1983;125:461-468.
Podda M, Ghezzi C, Battezzati PM, et al. Effects of ursodeoxycholic acid and taurine on serum liver enzymes and bile acids in chronic hepatitis.
Gastroenterology. 1990;98:1044-1050.
Shao A, Hathcock JN. Risk assessment for the amino acids taurine, l-glutamine and l-arginine.
Regul Toxicol Pharmacol.
2008 Jan 26.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.